Bolt Biotherapeutics (NASDAQ:BOLT – Get Rating) and Unity Biotechnology (NASDAQ:UBX – Get Rating) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, profitability, earnings and valuation. Earnings & Valuation This table compares Bolt Biotherapeutics and […]
Unity Biotechnology (NASDAQ:UBX – Get Rating) had its price target upped by Citigroup from $5.00 to $6.00 in a report published on Friday, The Fly reports. Several other equities analysts also recently commented on the company. Wedbush decreased their target price on Unity Biotechnology from $35.00 to $5.00 and set an outperform rating on the […]
Unity Biotechnology, Inc. (NASDAQ:UBX – Get Rating) saw a large drop in short interest in the month of May. As of May 15th, there was short interest totalling 952,200 shares, a drop of 17.2% from the April 30th total of 1,150,000 shares. Based on an average daily trading volume, of 417,800 shares, the days-to-cover ratio […]